Financial Data and Key Metrics Changes - For the fiscal year ending June 30, 2025, total revenue increased by 11% from $20.5 million to $22.6 million [5] - Recurring revenue rose by 10% to $22.3 million, with setup fees increasing from $95,000 in fiscal 2024 to over $300,000 in fiscal 2025 [5] - Total operating expenses increased by 6%, primarily due to investments in RTN and other development costs [5] - GAAP net income increased by 17% from $6 million to $7 million, with earnings per share growing by 21% [7][8] - Cash from operations rose by 21% from $7 million to $8.4 million, and total cash increased by 14% from $25.2 million to $28.6 million [8][10] Business Line Data and Key Metrics Changes - Annual recurring revenue continues to represent between 98% and 99% of total revenue, indicating strong stability in recurring income [8] - The growth in deferred revenue was 30%, increasing from $2.4 million to $3.2 million, reflecting future revenue potential [12] Market Data and Key Metrics Changes - The company is experiencing growth across all lines of business, including compliance and supply chain, not just traceability [11] - The traceability network is becoming increasingly significant, with a growing number of referrals coming from suppliers and manufacturers [22] Company Strategy and Development Direction - The company aims to grow annual recurring revenue between 10% to 20% while increasing profitability at a faster rate [4] - A focus on automation and efficiency is central to the company's strategy, with ongoing investments in AI-driven onboarding tools [5][24] - The company is shifting its marketing approach to target smaller accounts, expanding its total addressable market [19] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in continued growth and profitability, projecting that the business model will double in size over the next several years [10] - The company is well-positioned to meet traceability requirements, which are increasingly important in the industry [26] - Management noted that the FDA's change in compliance timelines has provided breathing room for effective rollout [26] Other Important Information - The company has zero bank debt and has returned over $25 million in capital to shareholders through share buybacks and dividends [10][16] - The capital allocation strategy includes a commitment to return 50% of annual cash from operations to shareholders [17] Q&A Session Summary Question: Did you change your pricing or billing strategy? - Management clarified that the automation allows them to effectively serve smaller accounts, changing their marketing and billing approach [30][31] Question: How have tariffs impacted your business? - Management indicated that tariffs have not significantly impacted the business so far, but there could be future effects on the food supply chain [32][33] Question: What are your thoughts on strategic M&A? - Management is open to opportunities but has nothing to announce at this time, indicating increased interest in potential acquisitions [35][36] Question: Would you consider paying a one-time dividend? - Management expressed a preference for increasing regular dividends rather than issuing a one-time dividend, focusing on long-term growth [38][39] Question: Do you have any crypto treasury plans? - Management confirmed that they have no plans to invest in cryptocurrency, citing a preference for stability and risk management [43]

Core Insights - Pharma-Bio Serv, Inc. reported revenues of approximately $2.0 million for the three months ended July 31, 2025, a decrease from $2.4 million in the same period of 2024 [1] - For the nine months ended July 31, 2025, revenues were approximately $6.9 million, down from $7.2 million for the same period in 2024 [1] Revenue Analysis - The revenue for the three months ended July 31, 2025, decreased by approximately 16.67% compared to the same period in 2024 [1] - The revenue for the nine months ended July 31, 2025, decreased by approximately 4.17% compared to the same period in 2024 [1]

For more information or to schedule a meeting with Safe Harbor during the conference, please contact Kimberly Ann Seefried at Kimberly.Seefried@shfinancial.org. About Safe Harbor DENVER, July 23, 2025 (GLOBE NEWSWIRE) -- SHF Holdings, Inc., d/b/a Safe Harbor Financial ("Safe Harbor" or the "Company") (NASDAQ: SHFS), a leader in providing reliable, compliant financial services to the regulated cannabis industry, announced CEO Terry Mendez will speak at the PBC Conference 2025, the premier B2B event for payme ...

Core Insights - Safe Harbor Financial, a fintech leader in the cannabis industry, is participating in the Benzinga Cannabis Capital Conference from June 8-10, 2025, in Chicago [1][2] - The CEO, Terry Mendez, will be part of a panel discussing financial resilience in the cannabis market on June 9, 2025 [2] - Safe Harbor has facilitated over $25 billion in deposit transactions for cannabis-related businesses across more than 41 states and territories [4] Company Overview - Safe Harbor provides compliance, monitoring, and validation services to financial institutions serving the cannabis, hemp, and CBD sectors [4] - The company emphasizes accountability, transparency, and risk mitigation while adhering to Bank Secrecy Act obligations [4] - Safe Harbor aims to foster long-term partnerships and drive growth in local economies through its services [4]

Core Insights - Safe Harbor Financial has formed a strategic partnership with Bennett Thrasher to enhance financial compliance and advisory services for cannabis businesses in regulated markets [1][2] - The collaboration aims to address financial challenges faced by operators in the cannabis industry, providing essential tools and guidance for growth [2][3] Company Overview - Safe Harbor Financial is a fintech leader that facilitates financial services and credit facilities specifically for the cannabis industry, having facilitated over $25 billion in deposit transactions across more than 41 states [8] - Bennett Thrasher is a prominent accounting and advisory firm with over 45 years of experience, offering a range of services including tax, audit, and advisory [4] Services Offered - The partnership provides a comprehensive suite of financial services tailored for cannabis businesses, including annual audits, tax preparation, ongoing financial advisory, corporate valuations, M&A support, and CFO services [6][7] - These services are designed to improve audit readiness, enhance credibility with stakeholders, and provide strategic financial guidance [7] Industry Context - Operators in the cannabis industry face unique financial challenges, such as navigating the complexities of 280E tax law and limited access to traditional advisory services [3] - The partnership aims to fill a critical gap in financial infrastructure, enabling cannabis businesses to operate with greater efficiency and confidence [2][3]